Table 2. Propertes of Different Geometric Isomers of AXTa.
property | type of isomer | type of assay | ref |
---|---|---|---|
antioxidant capacity | 13Z > all-E > 9Z | CAA assays (Caco2-BBe1/HT-29) | (61) |
13Z > 9Z > all-E | ORAC-L, PLC assays | (61) | |
9Z > 13Z > all-E | DPPH and lipid peroxidation assay (SH-SY5Y cells) | (62) | |
transport efficiency | 9Z > 13Z > all-E | Caco-2 cell monolayer model | (55) |
bioavailability/bioaccessibility | Z-isomers> all-E | oral-dosing test (human) | (63) |
all-E > 13Z > 9Z | oral-dosing test (rainbow trout) | (64) | |
13Z > 9Z, all-E | oral-dosing test (human) | (65) | |
13Z > 9Z> all-E | digestion model (Caco-2 cells) | (55) | |
stability | all-E > 9Z > 13Z | storage tests (heating and filtration) | (66) |
all-E, 13Z > 9Z | pH test | (61) | |
solubility | Z-isomers > all-E | organic solvents | (53) |
Abbreviations: ORAC-L assay, oxygen radical absorbing capacity assay for lipophilic compounds; PCL assay, photochemiluminescence assay; CAA assay, cellular antioxidant activity assay; DPPH, 2,2-diphenyl-1-picrylhydrazyl; bioaccessibility, the amount of AXT available for absorption in the gut after the digestion process; bioavailability, the amount of AXT which reaches the site of physiological activity after administration.25